Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Tulkens

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitroB K Kishore, Z Kállay, P Lambricht, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 16, 2014
Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997-2013)M Imöhl, R R Reinert, P M Tulkens, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 28, 2000
Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblastsM El Mouedden, G Laurent, M P Mingeot-Leclercq, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 12, 2005
Quinolones in 2005: an updateF Van Bambeke, J-M Michot, J Van Eldere, et al.
Life Sciences|January 1, 1994
Increased activities of cathepsin B and other lysosomal hydrolases in fibroblasts and bone tissue cultured in the presence of cysteine proteinases inhibitorsJ P Montenez, J M Delaissé, P M Tulkens, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapyF Van Bambeke, Y Glupczynski, P Plésiat, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1991
Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot studyF Meunier, P Van der Auwera, M Aoun, et al.
Journal of Molecular Microbiology and Biotechnology|August 11, 2000
Modeling of Enterococcus faecalis D-alanine:D-alanine ligase: structure-based study of the active site in the wild-type enzyme and in glycopeptide-dependent mutantsM Prévost, D Van Belle, P M Tulkens, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1987
Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophagesC Renard, H J Vanderhaeghe, P J Claes, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophagesM B Carlier, B Scorneaux, A Zenebergh, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitroB K Kishore, Z Kállay, P Lambricht, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 16, 2014
Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997-2013)M Imöhl, R R Reinert, P M Tulkens, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 28, 2000
Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblastsM El Mouedden, G Laurent, M P Mingeot-Leclercq, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 12, 2005
Quinolones in 2005: an updateF Van Bambeke, J-M Michot, J Van Eldere, et al.
Life Sciences|January 1, 1994
Increased activities of cathepsin B and other lysosomal hydrolases in fibroblasts and bone tissue cultured in the presence of cysteine proteinases inhibitorsJ P Montenez, J M Delaissé, P M Tulkens, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapyF Van Bambeke, Y Glupczynski, P Plésiat, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1991
Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot studyF Meunier, P Van der Auwera, M Aoun, et al.
Journal of Molecular Microbiology and Biotechnology|August 11, 2000
Modeling of Enterococcus faecalis D-alanine:D-alanine ligase: structure-based study of the active site in the wild-type enzyme and in glycopeptide-dependent mutantsM Prévost, D Van Belle, P M Tulkens, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1987
Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophagesC Renard, H J Vanderhaeghe, P J Claes, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophagesM B Carlier, B Scorneaux, A Zenebergh, et al.
Pageof 11